CVRdatabase
Menu

Var2 Pharmaceuticals ApS

Private limited companyCVR 34621942FrederiksbergActive

Var2 Pharmaceuticals ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2012. The company made a loss in both 2024 and 2025, most recently DKK 19.7m. Equity grew to DKK 82m in 2025. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 21.7m+4.2% vs. 2024
Net profit−DKK 19.7m+6.1% vs. 2024
EquityDKK 82m+27.3% vs. 2024
Employees10latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 21m to DKK 19.7m (2024 → 2025).
  • Equity rose 27% (2024 → 2025), to DKK 82m.

Employees

  • 1 fewer employees than a year earlier: 10 (08/2026) against 11 (08/2025).

Management and owners, last 24 months

  • New in management: Tanja Rainer (board member, 30/06/2025) and Silviya Stoykova (board member, 30/06/2025).

Registrations, last 24 months

  • 21/07/2025: Share capital changed from 109,643 DKK to 118,478 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40mDKK 60mDKK 80m202020212022202320242025
EquityNet profit
Financial figures for Var2 Pharmaceuticals ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−3,413−4,433−6,358−22,300−22,698−21,739+4.2%
Operating profit (EBIT)−6,871−7,552−9,147−25,574−28,557−26,352+7.7%
Profit before tax−7,033−7,474−8,988−24,029−26,230−24,363+7.1%
Net profit−5,390−5,905−6,805−19,119−21,006−19,727+6.1%
Total assets44,76338,46170,16859,34566,70285,739+28.5%
Equity42,90036,99567,38548,26664,45682,032+27.3%
Liabilities1,8631,4662,78311,0782,2463,707+65%
Cash and cash equivalents35,45729,30158,27140,92541,33048,032+16.2%
Average number of employees875687−12.5%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 25m−DKK 20m−DKK 15m−DKK 10m−DKK 5mDKK 0202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Var2 Pharmaceuticals ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202508/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202427/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202327/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202202/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202120/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202028/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101209/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 21.7mNo. 406 of 421
Better than 4% of the companies in the industry
EquityDKK 82mNo. 43 of 431
Better than 90% of the companies in the industry
Number of employees10No. 173 of 431
Better than 60% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,701of 69,742
Better than 0%
No. 2,130of 69,964
Better than 97%
Same industry and fewer than 20 employees329 companies in the comparison
No. 317of 323
Better than 2%
No. 8of 329
Better than 98%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,550of 33,588
Better than 0%
No. 819of 33,687
Better than 98%
All companies of type ApS66,508 companies in the comparison
No. 66,338of 66,379
Better than 0%
No. 1,368of 66,505
Better than 98%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Var2 Pharmaceuticals ApS−DKK 21.7m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Var2 Pharmaceuticals ApS−DKK 19.7m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Var2 Pharmaceuticals ApSDKK 82m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Var2 Pharmaceuticals ApS10
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Københavns Universitet5%
  • Oncomal ApS90%
Var2 Pharmaceuticals ApS
Subsidiaries and ownership shares

Subsidiaries are shown only if they are in the database.

Management

10 active registrations

Executive management

Executive management at Var2 Pharmaceuticals ApS
NameRoleAppointed
Ali El-SalantiDirector01/06/2012
Mads DaugaardDirector01/06/2012

Board of directors

Board of directors at Var2 Pharmaceuticals ApS
NameRoleAppointed
Thor Grundtvig TheanderBoard member14/05/2016
Ali El-SalantiBoard member14/05/2016
Mads DaugaardChair of the board14/05/2016
Peter SchröcksnadelBoard member14/05/2016
Poul Henrik Bredahl SørensenBoard member14/05/2016
Josef RainerBoard member01/04/2022
Tanja RainerBoard member30/06/2025
Silviya StoykovaBoard member30/06/2025
Founders
Oncomal ApS, Københavns Universitet
Former management (3)
Former management at Var2 Pharmaceuticals ApS
NameRoleAppointedResigned
Thor Grundtvig TheanderDirector01/06/201218/01/2018
Mai-Britt ZoccaBoard member14/05/201618/05/2019
Ulf Andreas Linderoth NorlinDirector18/01/201831/03/2020

Signing rule: Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør eller af den samlede bestyrelse.

Address and production units

1 active production units

Nordre Fasanvej 215
2000 Frederiksberg

Frederiksberg Municipality · Postcode 2000

Other companies at the address (8)

  • Sparrow Quantum ApSManufacture of computers and peripheral equipment
  • Adcendo ApSResearch and experimental development on natural sciences and engineering
  • Hemab ApSManufacture of pharmaceutical preparations
  • Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
  • Minervax ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
VAR2 PHARMACEUTICALS ApSNordre Fasanvej 215, 2000 Frederiksberg101017829218

Purpose

Selskabets formål er - direkte eller via besiddelse af kapitalandele i andre selskabet - at drive virksomhed indenfor kræftbekæmpelse samt anden virksomhed, der efter direktionens skøn er forbundet dermed.

The purpose is quoted from the register in Danish.

Changes year by year

36 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20255 changescapital 1 · management 2 · accounts 1 · industry 1
  • Share capital changed from 109,643 DKK to 118,478 DKK
  • Silviya Stoykova appointed board member
  • Tanja Rainer appointed board member
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20243 changesaccounts 1 · capital 1 · address 1
  • Annual report for 2023 published
  • Share capital changed from 105,284 DKK to 109,643 DKK
  • Moved to Nordre Fasanvej 215, 2000 Frederiksberg
20231 changeaccounts 1
  • Annual report for 2022 published
20223 changesaccounts 1 · capital 1 · management 1
  • Annual report for 2021 published
  • Share capital changed from 100,925 DKK to 105,284 DKK
  • Josef Rainer appointed board member
20211 changeaccounts 1
  • Annual report for 2020 published
20201 changemanagement 1
  • Ulf Andreas Linderoth Norlin stepped down as director
20191 changemanagement 1
  • Mai-Britt Zocca stepped down as board member
20184 changescapital 2 · management 2
  • Share capital changed from 96,566 DKK to 100,925 DKK
  • Share capital changed from 95,607 DKK to 96,566 DKK
  • Ulf Andreas Linderoth Norlin appointed director
  • Thor Grundtvig Theander stepped down as director
20171 changecapital 1
  • Share capital changed from 94,648 DKK to 95,607 DKK
20167 changescapital 1 · management 6
  • Share capital changed from 93,689 DKK to 94,648 DKK
  • Peter Schröcksnadel appointed board member
  • Poul Henrik Bredahl Sørensen appointed board member
  • Ali El-Salanti appointed board member
  • Mai-Britt Zocca appointed board member
  • Thor Grundtvig Theander appointed board member
  • Mads Daugaard appointed chair of the board
20151 changecapital 1
  • Share capital changed from 88,889 DKK to 93,689 DKK
20132 changescapital 1 · ownership 1
  • Share capital changed from 86,486 DKK to 88,889 DKK
  • ONCOMAL ApS registered as owner (90%)
20125 changesfounded 1 · management 3 · ownership 1
  • Registered as VAR2 PHARMACEUTICALS ApS
  • Thor Grundtvig Theander appointed director
  • Mads Daugaard appointed director
  • Ali El-Salanti appointed director
  • Københavns Universitet registered as owner (5%)

Related companies

Same industry in Frederiksberg

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction